Penumbra Net Income From Continuing Ops Over Time
| PEN Stock | USD 244.15 4.81 1.93% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Penumbra Performance and Penumbra Correlation. Penumbra |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.261 | Earnings Share 0.88 | Revenue Per Share 30.081 | Quarterly Revenue Growth 0.111 | Return On Assets 0.0333 |
The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income From Continuing Ops Analysis
Compare Penumbra and related stocks such as ReShape Lifesciences, Bone Biologics Corp, and Tivic Health Systems Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RSLS | (26 M) | (26 M) | (23.5 M) | (25.8 M) | (26.1 M) | (25.5 M) | (23.4 M) | (33.8 M) | (35.3 M) | (74.2 M) | (21.6 M) | (61.9 M) | (46.2 M) | (26.2 M) | (27.5 M) |
| BBLG | (4.4 M) | (4.4 M) | (4.4 M) | (4.4 M) | (4.4 M) | (13.9 M) | (21 M) | (7.1 M) | (4.4 M) | (3.4 M) | (1.8 M) | (1.6 M) | (1.5 M) | (6.5 M) | (6.8 M) |
| TIVC | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (3.6 M) | (8.5 M) | (10.1 M) | (8.2 M) | (8.7 M) |
| NUWE | (13.4 M) | (13.4 M) | (13.4 M) | (13.4 M) | (13.4 M) | (13.4 M) | (13.4 M) | (13.4 M) | (17 M) | (18.1 M) | (15.8 M) | (19.6 M) | (14.5 M) | (16.6 M) | (17.4 M) |
| NAOV | (2.6 M) | (2.6 M) | (2.6 M) | (2.6 M) | (2.6 M) | (2.9 M) | (2.8 M) | (5 M) | (4.2 M) | (5.8 M) | (4.3 M) | (14.3 M) | (5.4 M) | (5 M) | (5.2 M) |
| NXL | (3.4 M) | (3.4 M) | (3.4 M) | (3.4 M) | (3.4 M) | (3.4 M) | (3.4 M) | (3.4 M) | (3.4 M) | (3.4 M) | (3.4 M) | (6.1 M) | (1.7 M) | (4.6 M) | (4.8 M) |
| BJDX | (819.8 K) | (819.8 K) | (819.8 K) | (819.8 K) | (819.8 K) | (819.8 K) | (819.8 K) | (819.8 K) | (819.8 K) | (819.8 K) | (1.2 M) | (3.5 M) | (9.3 M) | (10 M) | (9.5 M) |
| IRIX | 2.1 M | 2.1 M | (170 K) | 2.2 M | 10 M | 474 K | (11.7 M) | (12.9 M) | (12.8 M) | (8.8 M) | (6.3 M) | (5.2 M) | (7.5 M) | (9.6 M) | (9.1 M) |
| HSDT | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (9.8 M) | (6.9 M) | (12 M) | (28 M) | (28.6 M) | (9.8 M) | (14.1 M) | (18.1 M) | (14.1 M) | (12.7 M) | (13.3 M) |
Penumbra and related stocks such as ReShape Lifesciences, Bone Biologics Corp, and Tivic Health Systems Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| Penumbra | PEN |
| Classification | Medical Equipment |
| Location | California; U.S.A |
| Exchange | New York Stock Exchange |
USD 244.15
Check out Penumbra Performance and Penumbra Correlation. To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Penumbra technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.